FGM:NASDAQFirst Trust Germany AlphaDEX Fund Analysis

The fund is trading at $64.35, just below its 20‑day and 50‑day simple moving averages of $64.73 and $64.72, indicating a modest short‑term pullback. Nevertheless, it remains comfortably above the 200‑day SMA of $62.18, confirming the longer‑term bullish bias. The 14‑day RSI sits at 49, suggesting neutral momentum without clear overbought or oversold pressure. A bearish MACD histogram of –0.28 and a MACD signal labeled “bearish” point to potential downside momentum in the near term. Support at $61.60 and resistance near $67.11 provide a clear price corridor, with the current level offering a modest cushion above support. Trading volume has been increasing, outpacing the 10‑day average of 4,680 shares, which adds confidence to price moves. Market sentiment, as reflected by an extreme‑greed reading of 89.86 on the Fear & Greed Index, underscores a broadly optimistic environment for risk assets.
The ETF’s beta of 1.19 and a 30‑day volatility of 25% signal higher sensitivity to market swings than the broader index. A max drawdown of –17.8% over the observed period further highlights the potential for sizable corrections. With an expense ratio of 0.80% and zero tracking error, the fund tracks its German AlphaDEX benchmark tightly but at a relatively high cost. Its focused regional exposure to Germany elevates sector‑concentration risk to a high level, while the underlying euro‑denominated holdings introduce medium currency risk for U.S. investors. Liquidity appears moderate; the latest daily volume of 881 shares is well below the three‑month average of 10,863, suggesting some execution risk for larger trades. Given the blend of bullish long‑term trends, elevated short‑term momentum warnings, and heightened risk factors, a balanced stance is prudent. We therefore recommend a hold position for the short term, a buy for the medium horizon, and a cautious hold for the long term, each supported by the outlined risk and reward considerations.